268 related articles for article (PubMed ID: 29055148)
1. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study.
Kim JW; Lee CK; Rhee SY; Oh CH; Shim JJ; Kim HJ
J Gastroenterol Hepatol; 2018 Apr; 33(4):847-854. PubMed ID: 29055148
[TBL] [Abstract][Full Text] [Related]
2. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.
Bähler C; Vavricka SR; Schoepfer AM; Brüngger B; Reich O
BMC Gastroenterol; 2017 Dec; 17(1):138. PubMed ID: 29197335
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal trends in direct costs and healthcare utilization ascribable to inflammatory bowel disease in the biologic era: a nationwide, population-based study.
Park EY; Baek DH; Kim GH; Kim C; Kim H; Lee JW; Song GA
J Gastroenterol Hepatol; 2023 Sep; 38(9):1485-1495. PubMed ID: 37129098
[TBL] [Abstract][Full Text] [Related]
4. Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the future.
van der Have M; Mangen MJ; van der Valk ME; Smeets HM; van Bodegraven A; Dijkstra G; Fidder HH; de Jong DJ; Pierik M; Ponsioen CY; van der Meulen-de Jong AE; van der Woude CJ; van de Meeberg PC; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; Bolwerk CJ; Vermeijden JR; Siersema PD; Leenders M; Oldenburg B; ;
Inflamm Bowel Dis; 2014 Apr; 20(4):637-45. PubMed ID: 24518606
[TBL] [Abstract][Full Text] [Related]
5. Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Lee J; Im JP; Han K; Kim J; Lee HJ; Chun J; Kim JS
Gut Liver; 2020 Jan; 14(1):89-99. PubMed ID: 31158951
[No Abstract] [Full Text] [Related]
6. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
[TBL] [Abstract][Full Text] [Related]
7. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
[TBL] [Abstract][Full Text] [Related]
8. Emerging trends of inflammatory bowel disease in South Korea: A nationwide population-based study.
Kwak MS; Cha JM; Lee HH; Choi YS; Seo SI; Ko KJ; Park DI; Kim SH; Kim TJ
J Gastroenterol Hepatol; 2019 Jun; 34(6):1018-1026. PubMed ID: 30447025
[TBL] [Abstract][Full Text] [Related]
9. Long-term evolution of direct healthcare costs for inflammatory bowel diseases: a population-based study (2006-2015).
Kim JW; Lee CK; Lee JK; Jeong SJ; Oh SJ; Moon JR; Kim HS; Kim HJ
Scand J Gastroenterol; 2019 Apr; 54(4):419-426. PubMed ID: 30905222
[No Abstract] [Full Text] [Related]
10. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
Click B; Lopez R; Arrigain S; Schold J; Regueiro M; Rizk M
Inflamm Bowel Dis; 2020 Jul; 26(8):1268-1275. PubMed ID: 31671186
[TBL] [Abstract][Full Text] [Related]
11. Mental Health Costs of Inflammatory Bowel Diseases.
Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
[TBL] [Abstract][Full Text] [Related]
12. [Cost-of-illness study of asthma in Korea: estimated from the Korea National Health insurance claims database].
Park CS; Kang HY; Kwon I; Kang DR; Jung HY
J Prev Med Public Health; 2006 Sep; 39(5):397-403. PubMed ID: 17076180
[TBL] [Abstract][Full Text] [Related]
13. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland.
Bähler C; Schoepfer AM; Vavricka SR; Brüngger B; Reich O
Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):916-925. PubMed ID: 28471826
[TBL] [Abstract][Full Text] [Related]
14. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
[TBL] [Abstract][Full Text] [Related]
15. [Does the hospital cost of care differ for inflammatory bowel disease patients with or without gastrointestinal infections? A case-control study].
Schmidt C; Köhler F; Kräplin T; Hartmann M; Lerch MM; Stallmach A
Z Gastroenterol; 2014 Jul; 52(7):643-8. PubMed ID: 25026005
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients.
Yang BR; Choi NK; Kim MS; Chun J; Joo SH; Kim H; Lee J
PLoS One; 2018; 13(7):e0200363. PubMed ID: 29990326
[TBL] [Abstract][Full Text] [Related]
17. Health plan utilization and costs of specialty drugs within 4 chronic conditions.
Gleason PP; Alexander GC; Starner CI; Ritter ST; Van Houten HK; Gunderson BW; Shah ND
J Manag Care Pharm; 2013 Sep; 19(7):542-8. PubMed ID: 23964615
[TBL] [Abstract][Full Text] [Related]
18. High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
Murthy SK; James PD; Antonova L; Chalifoux M; Tanuseputro P
PLoS One; 2017; 12(5):e0177211. PubMed ID: 28498877
[TBL] [Abstract][Full Text] [Related]
19. Trends in paediatric inflammatory bowel disease-attributable direct costs: a population-based analysis.
El-Matary W; Nugent Z; Witt J; Bernstein CN
Aliment Pharmacol Ther; 2021 Jun; 53(11):1201-1208. PubMed ID: 33836105
[TBL] [Abstract][Full Text] [Related]
20. Forecasting the future prevalence of inflammatory bowel disease in Korea through 2048: an epidemiologic study employing autoregressive integrated moving average models.
Kim JE; Oh SJ; Lee CK;
J Gastroenterol Hepatol; 2024 May; 39(5):836-846. PubMed ID: 38233639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
